Odomzo 200mg Capsule is a hedgehog pathway inhibitor used to treat patients with locally advanced, recurrent, and metastatic basal cell carcinoma in adults. Its primary effect lies in blocking activity from the Smoothened protein, an important component of the hedgehog cellular signaling pathway involved in maintaining homeostasis within cells. This causes these cells to die off or stop growing, helping to reduce tumor size and prevent it from spreading further. Odomzo Capsule does not, however, affect other types of normal cells, making it a less aggressive treatment than many other anti-cancer therapies available today.